Lucia Pedrosa
Overview
Explore the profile of Lucia Pedrosa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
86
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stewart S, Seco-Meseguer E, Diago-Sempere E, Marin-Candon A, Carmona M, Estebanez M, et al.
BMJ Open
. 2024 Nov;
14(11):e089823.
PMID: 39510769
Introduction: Genetic variations impact drug response, driving the need for personalised medicine through pre-emptive pharmacogenetic testing. However, the adoption of pre-emptive pharmacogenetic testing for commonly prescribed drugs, such as statins,...
2.
Fernandez-Miranda I, Pedrosa L, Gonzalez-Rincon J, Espinet B, de la Cruz Vicente F, Climent F, et al.
Mod Pathol
. 2024 May;
37(7):100516.
PMID: 38763418
Follicular lymphoma (FL) is the most frequent indolent lymphoma. Some patients (10%-15%) experience histologic transformation (HT) to a more aggressive lymphoma, usually diffuse large B-cell lymphoma (DLBCL). This study aimed...
3.
Sanchez-Beato M, Mendez M, Guirado M, Pedrosa L, Sequero S, Yanguas-Casas N, et al.
Clin Transl Oncol
. 2023 Sep;
26(5):1043-1062.
PMID: 37672206
The new lymphoma classifications (International Consensus Classification of Mature Lymphoid Neoplasms, and 5th World Health Organization Classification of Lymphoid Neoplasms) include genetics as an integral part of lymphoma diagnosis, allowing...
4.
Fernandez-Miranda I, Pedrosa L, Llanos M, Franco F, Gomez S, Martin-Acosta P, et al.
Clin Cancer Res
. 2022 Oct;
29(1):209-220.
PMID: 36269794
Purpose: Follicular lymphoma (FL) is the most frequent indolent non-Hodgkin lymphoma. Around 20% of patients suffer early disease progression within 24 months (POD24) of diagnosis. This study examined the significance...
5.
Yanguas-Casas N, Pedrosa L, Fernandez-Miranda I, Sanchez-Beato M
Cancers (Basel)
. 2021 Jul;
13(12).
PMID: 34207773
Lymphoma research is a paradigm of the integration of basic and clinical research within the fields of diagnosis and therapy. Clinical, phenotypic, and genetic data are currently used to predict...
6.
Pedrosa L, Fernandez-Miranda I, Perez-Callejo D, Quero C, Rodriguez M, Martin-Acosta P, et al.
Sci Rep
. 2021 Jan;
11(1):1886.
PMID: 33479306
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease whose prognosis is associated with clinical features, cell-of-origin and genetic aberrations. Recent integrative, multi-omic analyses had led to identifying overlapping genetic...
7.
Barranco G, Fernandez S, Ona R, Gonzalez-Rincon J, Martinez-Ramirez A, Teijo A, et al.
Haematologica
. 2019 Mar;
104(7):e326-e329.
PMID: 30890596
No abstract available.
8.
Gonzalez-Rincon J, Mendez M, Gomez S, Garcia J, Martin P, Bellas C, et al.
PLoS One
. 2019 Feb;
14(2):e0212813.
PMID: 30802265
Follicular lymphoma (FL) is an indolent but largely incurable disease. Some patients suffer histological transformation to a more aggressive subtype with poorer prognosis. This study aimed to improve our understanding...
9.
Franco F, Gonzalez-Rincon J, Lavernia J, Garcia J, Martin P, Bellas C, et al.
Oncotarget
. 2017 Dec;
8(61):102888-102897.
PMID: 29262531
Primary breast lymphoma is a rare form of extra-nodal lymphoid neoplasm. The most common histological type is the diffuse large B-cell lymphoma, which represents 60-80% of all the cases. Our...